Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Return on Capital Employed of 42.3% for Q2 2026, up 2261.0% year-over-year from 1.79% in Q2 2025, and up 20.44% quarter-over-quarter from 53.17% in Q1 2026.
Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Return on Capital Employed for 2 consecutive years, with 42.3% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 2261.0% year-over-year to 42.3%; the TTM figure through Apr 2026 stood at 42.3% (up 2261.0% YoY), while the FY2026 annual figure was 48.69%, up 3137.0% from the prior year.
- Return on Capital Employed grew to 42.3% in Q2 2026 per KMTS's latest filing, from 53.17% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 42.3% in Q2 2026 and bottomed at 64.91% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | -42.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -42.30% |
| Jan 31, 2026 | -53.17% |
| Oct 31, 2025 | -58.64% |
| Jul 31, 2025 | -46.96% |
| Apr 30, 2025 | -64.91% |